MART1 (MLANA) levels are controlled by the melanocyte master transcription factor MITF57 and are widely used in melanoma diagnosis.58 Loss of MART1 expression reflects a fundamental change in tumor differentiation status (Supplementary Fig. S2F). This evidence concerns the gene MLANA and neoplasm.